The Utility of Ischemia Modified Albumin (IMA) in Sepsis

Clinical trial NCT00448968 · COMPLETED

Trial details

NCT number: NCT00448968
Sponsor: Inverness Medical Innovations
Status: COMPLETED
Study type: OBSERVATIONAL

Sepsis Severe Sepsis Systemic Inflammatory Response Syndrome Sepsis Syndrome

Start date: 2007-03-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.